The global neurological biomarkers market size was valued at USD 7 billion in 2021 and is poised to grow at a significant CAGR of 12.9% during the forecast period 2022-28. Neurological biomarkers are chemicals found in the blood or cerebral spinal fluid (CSF) that help diagnose and track the evolution of brain illnesses. Genetic mutations, metabolite levels, brain imaging, and changes in...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian